Inactive Instrument

Highlights Immunomedics, Inc.

Equities

IMMU

US4529071080

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Gilead Sciences : Raises Product Sales Guidance on Remdesivir Demand, Narrows Earnings Outlook for 2020	21-01-11	DJ
Gilead Sciences : to Pay $1.4 Billion for Hepatitis Drug Maker MYR GmbH of Germany	20-12-10	DJ
Gilead Sciences, Inc. completed the acquisition of Immunomedics, Inc..	20-10-22	CI
Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric Glioblastoma	20-10-12	CI
Immunomedics, Inc. Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy™ in Metastatic Urothelial Cancer	20-09-19	CI
Immunomedics, Inc.'s Trodelvy™ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast Cancer	20-09-19	CI
Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers	20-09-18	CI
Snowman Logistics : Buffett-backed Snowflake's value doubles in stock market's largest software debut	20-09-16	RE
Gilead Sciences : Tech, healthcare mega deals boost virus-stricken M&A market	20-09-15	RE
Seattle Genetics : Merck to buy $1 billion stake in Seattle Genetics, co-develop cancer therapy	20-09-14	RE
Gilead Sciences : Immunomedics Shares More Than Double After Gilead Deal	20-09-14	DJ
Gilead Sciences : Acquires Cancer-Drug Maker	20-09-14	DJ
News Highlights : Top Company News of the Day	20-09-14	DJ
Gilead Sciences : Reaches Deal to Buy Immunomedics for $21 Billion -- 5th Update	20-09-13	DJ
Gilead Sciences : Reaches Deal to Buy Immunomedics for $21 Billion--4th Update	20-09-13	DJ
Gilead Sciences : nears deal to buy Immunomedics for more than $20 billion - WSJ	20-09-13	RE
Gilead Sciences, Inc. entered into a definitive agreement to acquire Immunomedics, Inc. for $20.4 billion.	20-09-12	CI
Gilead Sciences : Nears Deal to Buy Immunomedics for More Than $20 Billion	20-09-12	DJ
Gilead Sciences : Nears Deal to Buy Immunomedics for More Than $20 Billion--3rd Update	20-09-12	DJ
Gilead Sciences : Nears Deal to Buy Immunomedics for More Than $20 Billion--2nd Update	20-09-12	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Immunomedics, Inc.

Equities

IMMU

US4529071080

Highlights

Filters